Educational disclaimer. This article is for procurement, regulatory-affairs, and BMET education. Regulatory environments evolve continuously — verify the current text of FDA 21 CFR Part 807, EU MDR 2017/745, ISO 13485, ISO 10993, AAMI EC12, and your destination market's medical-device regulation directly with the issuing authority before using citations in formal tender or registration documents. Standards revisions, transition deadlines, and certificate-renewal timelines change frequently; the information below reflects the landscape as understood at publication.
TL;DR
For disposable ECG electrodes, "FDA approved" is technically incorrect — Class II devices are cleared, not approved (and ECG electrodes also fall under a Class II special-controls framework). The compliance picture that authorizes a manufacturer to market ECG electrodes globally has four layers: (1) Establishment Registration + Device Listing with the FDA (mandatory but not a clearance); (2) 510(k) clearance under Product Code DRX / compliance with the applicable special controls for U.S. marketing; (3) CE marking under MDR 2017/745 with a Notified Body four-digit number for the EU; (4) NMPA registration, MDSAP, and other regional certifications for global reach. Behind these are the performance and safety standards: AAMI EC12 for electrical performance and ISO 10993-5/-10/-23 for biocompatibility. Almost every regulatory claim a supplier makes can be verified in 15–30 minutes through public databases — this guide shows exactly how.
📑 Table of contents
- Why compliance verification matters more than the marketing claim
- The 4-layer FDA compliance pyramid for ECG electrodes
- Decoding a 510(k) K-number and reading the Summary
- CE marking under MDR 2017/745 — post-transition reality
- ISO 13485 verification: beyond the certificate logo
- AAMI EC12: how to read the performance test report
- ISO 10993 biocompatibility for 24–48h skin contact
- Sterile vs non-sterile: the regulatory difference most buyers miss
- 7-step verification protocol (30 minutes per supplier)
- Region-by-region "must have" vs "nice to have"
- Frequently asked questions
- References & standards
A U.S. hospital procurement officer received three quotes for disposable ECG electrodes. The price spread was 38% top to bottom. Two suppliers prominently advertised "FDA approved"; one said "FDA registered." The lowest-priced supplier showed a slick certificate that turned out to be an Establishment Registration acknowledgment — not a 510(k) clearance. The hospital almost issued a USD 280,000 PO before the BMET caught the discrepancy in a 15-minute database lookup.
This article is the database-level verification protocol for that lookup. It walks through exactly which FDA, CE, ISO, and AAMI documents prove what — what each phrase means, where to verify it, and what red flags signal a misrepresentation. Compliance for disposable ECG electrodes is largely a public-database fact, and it can be verified in about 30 minutes per supplier with no specialist training.
📚 Part of MedLinket's ECG Electrodes Resource Hub. For the parent overview of structure, materials, and clinical scenarios, start with our ECG Electrodes Complete Buyer's & Clinical Guide. For the broader 12-criteria supplier-evaluation framework that places these regulatory checks within a complete scoring model, see How to Evaluate ECG Electrode Suppliers.
Why compliance verification matters more than the marketing claim
Short answer: ECG electrodes are FDA Class II devices in direct skin contact for 24 to 48 hours under occlusion. The combination of skin contact and prolonged wear places them in one of the more stringent regulatory categories among monitoring accessories, with biocompatibility testing, electrical-performance characterization, and a defined pre-market pathway. A supplier that conflates "FDA registered" with "FDA cleared" is at minimum careless and at worst misrepresenting regulatory status — neither is acceptable for a Class II device.
A regulatory nuance worth knowing. Since 2011, the FDA has regulated ECG electrodes under 21 CFR 870.2360, Class II, with "special controls" (a Class II Special Controls Guidance document defines the required device description, biocompatibility, electrical performance, adhesive performance, shelf life, and sterility documentation). For many electrode types this special-controls framework — rather than a fresh 510(k) for every product — is the operative pathway, while numerous electrodes remain cleared via 510(k). The practical point for buyers is unchanged: the manufacturer must be able to show it meets the applicable FDA requirements (a 510(k) clearance where one applies, and documented conformance to the special controls), not merely that its facility is "registered."
What is at stake
- Patient safety. Inadequately tested adhesive can cause contact dermatitis; inadequately tested gel can cause chemical irritation; uncharacterized AC impedance can produce signal artifacts that mimic clinical events and trigger false alarms.
- Customs and import. Non-compliant products are detained at U.S. ports of entry under 21 CFR; EU customs detain Class IIa devices without proper CE marking; Brazil ANVISA and China NMPA enforce equivalent rules.
- Hospital accreditation. The Joint Commission (U.S.), JCI (international), and DNV require traceable supplier documentation as part of regulated supply-chain compliance. Inability to produce the supplier's regulatory documentation during an accreditation audit is a finding.
- Tort exposure. When a patient develops an electrode-related adverse event, the chain of liability runs from the hospital to the distributor to the manufacturer. Each link must hold its own documentation.
- Recall risk. The FDA maintains a public Medical Device Recall database. A supplier with prior recalls in the same product family is a measurable risk factor regardless of current marketing claims.
The "FDA approved" linguistic trap. Class II devices are cleared through 510(k) (or regulated under Class II special controls); only Class III devices receive approval through PMA. The phrase "FDA approved ECG electrodes" is technically incorrect and is often used by suppliers who do not understand — or who deliberately blur — the distinction between FDA establishment registration (a facility listing), FDA device listing (a product identification), and FDA 510(k) clearance / special-controls compliance (the actual marketing authorization). The remainder of this article uses the precise framing: FDA authorization under Product Code DRX.
The 4-layer FDA compliance pyramid for ECG electrodes
Short answer: the FDA's regulation of disposable ECG electrodes is layered. Each layer has a different legal effect and a different verification method. Conflating the layers — accidentally or deliberately — is the single most common source of misrepresented compliance claims.
Layer 1 — Establishment Registration
Every facility manufacturing, repackaging, or relabeling a medical device for the U.S. market must register annually with the FDA via Form FDA 2891, producing an FEI (FDA Establishment Identifier) number. Establishment Registration is mandatory, but it is not a clearance. It does not authorize product marketing; it merely tells the FDA that a facility exists and what it claims to make. The FDA does not pre-inspect or pre-approve registrations.
Verify at: FDA Establishment Registration & Device Listing database (search by company name or FEI number).
Layer 2 — Device Listing
Each device a registered facility produces is listed on Form FDA 2892, which assigns its Product Code. For disposable ECG electrodes the Product Code is DRX (regulation 21 CFR 870.2360, "Electrode, electrocardiograph"). Listing is the second mandatory layer and, like registration, does not constitute clearance — it tells the FDA which product family the facility intends to make.
Layer 3 — 510(k) clearance / Class II special controls (the marketing authorization)
For a Class II device that is not exempt, Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires the manufacturer to demonstrate the device is substantially equivalent to a legally marketed predicate before marketing. Substantial equivalence (SE) is established by comparing intended use, technological characteristics, performance data (including AAMI EC12 testing for ECG electrodes), and biocompatibility (ISO 10993). If the FDA concurs, it issues a K-number clearance (e.g., K252345). For ECG electrodes specifically, the FDA also maintains a Class II special-controls framework (21 CFR 870.2360): a manufacturer must meet those special controls — documented device description, biocompatibility, electrical performance, adhesive performance, shelf life, and sterility — whether or not a separate 510(k) applies to a given electrode. Either way, the manufacturer must be able to show the FDA's requirements are met before the device is legally marketed in the U.S.
The "compatible electrode" subtlety. A supplier marketing electrodes "compatible with Philips" or "compatible with GE" is not exempt from FDA requirements. The manufacturer still needs its own FDA authorization (a 510(k) clearance where one applies, plus conformance to the applicable special controls) demonstrating safety and performance. Compatibility refers to the physical and electrical interface; FDA authorization refers to safety and performance. They are independent regulatory facts. For the interface side, see our 4.0 mm snap ECG electrodes guide; for brand-level cross-reference, see the OEM-compatible ECG electrodes guide.
Layer 4 — PMA (Premarket Approval)
PMA is the FDA's most rigorous review path, reserved for Class III devices that support or sustain human life or pose significant risk. Disposable ECG electrodes are Class II — they do not require PMA. Any supplier claiming "FDA PMA" for ECG electrodes is either confused or misrepresenting regulatory status.
Decoding a 510(k) K-number and reading the Summary
Short answer: a K-number is an identifier following the letter K (e.g., K252345). The first two digits encode the FDA fiscal year of receipt; the remaining digits are sequential. Every 510(k) clearance has a corresponding public 510(k) Summary or Statement on the FDA website, retrievable in under five minutes.
K-number anatomy
Example: K203456 was received in FDA fiscal year 2020 (1 Oct 2019 – 30 Sep 2020). A supplier whose only 510(k) predates 2010 is operating under a clearance that may carry technological assumptions older than current AAMI EC12 expectations — not necessarily disqualifying, but worth understanding.
How to look up a K-number on the FDA website
- Go to the FDA 510(k) Premarket Notification database at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm.
- Enter the K-number in the "510(k) Number" field, or search by applicant name or Product Code (DRX for disposable ECG electrodes).
- The result page lists decision date, applicant, device name, product code, and a link to the 510(k) Summary or Statement.
- Open the Summary PDF. Confirm: device description matches the SKU you are buying; product code is DRX; predicate device cited; intended-use language matches the supplier's marketing.
- Cross-check the FDA "Establishment Registration & Device Listing" entry for the same applicant to confirm the manufacturing facility location matches the supplier's claimed location.
What to look for in the 510(k) Summary
| Section | What to verify |
|---|---|
| Device trade name | Matches the SKU on the supplier's quote |
| Common / usual name | "Electrode, electrocardiograph" or equivalent |
| Classification name | Class II per 21 CFR 870.2360 |
| Product code | DRX |
| Predicate device(s) | K-number(s) cited as the substantial-equivalence basis |
| Indications for use | Adult / pediatric / neonatal monitoring scope |
| Performance standards | AAMI EC12 referenced; ISO 10993-5/-10 referenced |
| Sterility (if applicable) | EO sterilization with SAL = 10⁻⁶ stated for sterile-coded variants |
CE marking under MDR 2017/745 — post-transition reality
Short answer: the EU Medical Device Regulation 2017/745 (MDR) replaced the prior Medical Device Directive (MDD) 93/42/EEC. The transition for many Class IIa devices (including disposable ECG electrodes) concluded in 2024. Any electrode marketed in the EU as of 2026 should hold valid MDR certification — old MDD certificates generally cannot support new EU placement; confirm the current transition rules for your situation.
What MDR requires for ECG electrodes
- Classification: Class IIa under the Annex VIII rules, as a non-invasive skin-contact monitoring device.
- Notified Body involvement: mandatory. A four-digit Notified Body number must appear adjacent to the CE mark on labeling and packaging.
- Technical documentation: Annex II (Technical Documentation) and Annex III (Post-Market Surveillance) available to competent authorities on request.
- EUDAMED registration: manufacturer, Authorised Representative, and device data registered in the European Database on Medical Devices.
- EU Authorised Representative (EC REP): manufacturers outside the EU must designate an EC REP whose name and address appear on the labeling.
- Person Responsible for Regulatory Compliance (PRRC): the manufacturer must designate a qualified PRRC.
- Unique Device Identification (UDI): mandatory machine-readable UDI on packaging.
- Post-Market Surveillance (PMS) and Periodic Safety Update Report (PSUR): required and updated at intervals defined by the Notified Body.
How to verify a CE marking
- Check the labeling and packaging for the CE mark followed by a four-digit Notified Body number (e.g., "CE 0123").
- Verify the Notified Body's authorization scope at the EU NANDO database (ec.europa.eu/growth/tools-databases/nando). Confirm it is designated for Regulation 2017/745 and for Class IIa monitoring devices.
- Request the full CE certificate PDF — including all scope pages. Verify the validity date (MDR certificates have a maximum 5-year validity).
- Verify the EC REP information appears on the certificate and on the product labeling.
- Cross-check the manufacturer and device entry in EUDAMED if accessible to your role.
The MDD-vs-MDR transition pitfall. Some suppliers still circulate old MDD-era certificates. A genuine MDR certificate explicitly references "Regulation (EU) 2017/745" — not "Directive 93/42/EEC." If a supplier shows a certificate citing only the older Directive, it generally cannot support new EU market entry in 2026.
ISO 13485 verification: beyond the certificate logo
Short answer: ISO 13485:2016 is the medical-device-specific quality-management standard. It is not interchangeable with ISO 9001 (which is generic), and the certificate's value depends entirely on whether the issuing certification body is itself accredited under the IAF MLA (International Accreditation Forum Multilateral Recognition Arrangement). Note too that since February 2026 the FDA's Quality Management System Regulation (QMSR) incorporates ISO 13485:2016 by reference, so this alignment now matters on both sides of the Atlantic.
Three-step ISO 13485 verification
- Verify the certificate scope. The scope page must explicitly include "ECG electrodes," "disposable ECG electrodes," "biopotential electrodes," or equivalent. Generic scope language ("medical devices") is insufficient — it does not tell you whether ECG electrode manufacturing is within the audited operation.
- Verify the issuing certification body. Recognized bodies include BSI, TÜV SÜD, TÜV Rheinland, DEKRA, DNV, SGS, Intertek, and equivalents. The body must be accredited by an Accreditation Body that is a signatory to the IAF MLA. Look it up in the IAF MLA signatory list at iaf.nu.
- Verify the certificate is current and valid. Use the certification body's online verifier. Confirm the issue date, expiration date (typically a 3-year cycle with annual surveillance audits), and that the certificate is not suspended or withdrawn.
Key red flags in ISO 13485 documentation
ISO 9001 is generic. It lacks the design-control, sterilization-validation, biocompatibility-evaluation, lot-traceability, and post-market-surveillance requirements that govern medical-device manufacturing. For Class II skin-contact devices, ISO 9001-only is a disqualifying signal.
If the issuing body is not an IAF MLA signatory member, the certificate may not be recognized internationally — meaning customs, accreditation auditors, and other authorities may not accept it as valid evidence of compliance.
Suppliers showing only the front page while withholding the scope page are hiding what the certificate actually covers. The scope page must be reviewed before accepting the certification as evidence of ECG electrode manufacturing compliance.
A certificate within 60 days of expiry without documented renewal in progress is a red flag. Surveillance audits and recertification are predictable; failure to renew on schedule indicates either organizational dysfunction or audit-finding remediation issues.
AAMI EC12: how to read the performance test report
Short answer: AAMI EC12 (formally ANSI/AAMI EC12:2000(R)2020) is the U.S. performance standard for disposable ECG electrodes. It defines five electrical-performance parameters that determine signal quality and downstream false-alarm rate. Compliance is the regulatory floor; margin above the floor is what predicts clinical performance.
The five EC12 parameters and what they mean
| Parameter | EC12 limit | What it predicts clinically | MedLinket tested |
|---|---|---|---|
| AC impedance, average (10 Hz) | ≤ 2,000 Ω | Baseline signal quality; lower = less drift artifact | 109 Ω |
| AC impedance, single-piece maximum | ≤ 3,000 Ω | Inter-piece consistency; tighter = lower false-alarm variance | 120 Ω |
| DC offset voltage | ≤ 100 mV | Polarization drift; lower = better long-wear stability | 4.11 mV |
| Bias-current tolerance | ≤ 100 mV offset shift under bias | Stability against monitor bias currents | ≤ 5.1 mV |
| Combined offset instability & noise | ≤ 150 µV peak-to-peak | Signal-to-noise; lower = fewer false arrhythmia triggers | 49.5 µV |
The "MedLinket tested" values are registered platform values from MedLinket's NMPA registration test report — all well within the EC12 limits. Request the lot-level report for a specific SKU before tender approval.
EC12 also specifies defibrillation overload recovery (the electrode must recover baseline signal quality within a defined time after a defibrillation pulse) and simulated patient testing. These are pass/fail tests rather than continuous parameters; a quality manufacturer documents them, but they do not differentiate suppliers the way the five core parameters do.
What a real EC12 test report looks like
A genuine third-party AAMI EC12 test report includes:
- Test laboratory identification — name, accreditation status (ideally GLP or ISO/IEC 17025), and signatory.
- Test article description — exact SKU, lot number, manufacturing date.
- Sample size — typically 12 to 24 electrodes per parameter; smaller samples indicate weaker statistical confidence.
- Numerical values for each parameter — not just "compliant." Mean, standard deviation, minimum, maximum.
- Test methodology reference — citation to the specific EC12 section for each measurement.
- Date and signature — recent (within the lot's production window for lot-level reports).
Pass/fail vs. numerical value. A supplier providing only "AAMI EC12 compliant" without numerical values is giving the regulatory floor without the differentiation. Two electrodes can both "pass" EC12 at AC impedance of 1,800 Ω and 109 Ω — but the second produces a measurably lower clinical false-alarm rate. Always request the numerical values; suppliers that refuse are either hiding marginal performance or have not tested at the lot level. For the clinical-impact analysis of EC12 margins, see offset vs. center-post ECG electrodes.
ISO 10993 biocompatibility for 24–48h skin contact
Short answer: disposable ECG electrodes are categorized under ISO 10993-1 as "surface-contacting devices, intact skin, prolonged contact (greater than 24h to 30 days)." This category requires at minimum three biocompatibility test domains: cytotoxicity (-5), skin sensitization (-10), and skin irritation (the latter increasingly addressed under -23 since the 2021 ISO 10993-23 introduction).
The three required ISO 10993 sub-parts
Tests whether the adhesive and gel formulations release substances that kill cultured cells (typically L929 mouse fibroblasts) under controlled extraction. The test produces a cytotoxicity grade (0–4); for acceptance the grade should be ≤ 2.
What to verify: the test-article description must reference the actual adhesive and gel formulation in the product you are buying — not a generic family. "Representative sample" reports without the specific formulation are inadequate for procurement.
Historically the primary skin-contact test (guinea-pig maximization or Buehler), or more recently in-chemico/in-vitro alternatives (DPRA, KeratinoSens, h-CLAT) following the 2021 ISO 10993-23 split.
What to verify: test method, a result negative for sensitization, and that the test article matches the actual product.
Introduced in 2021 to consolidate skin-irritation testing previously distributed across -10. Uses reconstructed human epidermis (RhE) models. Any "ISO 10993-10 only" report dated well after 2021 may be missing the irritation domain that -23 now formally covers.
What to verify: test article matches; result is "non-irritant"; report reflects the updated standard.
For sterile (-S-) electrodes, ISO 10993-7 (residual ethylene oxide) verifies post-sterilization residual EO is within the prolonged-contact limit. For pediatric/neonatal applications, additional chemical characterization (ISO 10993-18) may be requested by FDA reviewers.
Why this matters disproportionately for ECG electrodes
The skin's three barrier systems — microbial (resident flora at a slightly acidic pH ~4.5–6.5), chemical (the lipid acid mantle of ceramides, free fatty acids, and cholesterol), and physical (the 12–20 layer stratum-corneum brick-and-mortar structure) — are simultaneously challenged during 24- to 48-hour wear: the microbial layer by sweat occlusion, the chemical layer by adhesive components, and the physical layer by edge friction from lead-wire forces. ISO 10993-10 and -23 testing is the regulatory anchor that the adhesive design will not destabilize these barriers within the intended wear time.
Suppliers claiming "hypoallergenic" or "low-allergy" without ISO 10993-10/-23 third-party reports on the actual production formulation are making marketing claims without substantiation. For the material-science background, see our low-allergy ECG electrodes explainer.
Sterile vs non-sterile: the regulatory difference most buyers miss
Short answer: sterile ECG electrodes (marked with an "-S-" suffix in MedLinket's coding) are subject to additional standards beyond the non-sterile equivalent — EO sterilization validation under EN ISO 11135, sterile-barrier-system validation under ISO 11607-1/-2, and residual EO testing under ISO 10993-7. The procurement implication: sterile and non-sterile variants of the "same" electrode are regulatorily distinct products with separate documentation packs.
What sterile-coded electrodes legally require
| Standard | What it covers | What to request |
|---|---|---|
| EN ISO 11135 | Ethylene oxide sterilization process validation | Process validation report; cycle parameters (temp, humidity, EO concentration, dwell time) |
| ISO 11607-1 | Sterile barrier system requirements | Pouch material specification; seal-integrity testing (ASTM F1929 dye penetration, F88 peel strength) |
| ISO 11607-2 | Sterile barrier system validation | Packaging validation report; aging study; transit testing |
| ISO 11737-1 | Bioburden determination | Pre-sterilization bioburden testing per lot or validation period |
| ISO 10993-7 | Residual ethylene oxide testing | Residual EO within the prolonged-contact device limit |
| EN 868 series | Specific sterile packaging materials | Pouch material certification (e.g., medical-grade Tyvek, paper-film laminate) |
SAL = 10⁻⁶ — the medical sterility benchmark
A Sterility Assurance Level (SAL) of 10⁻⁶ is the standard for terminally sterilized medical devices marketed in the U.S., EU, and most regulated markets: the probability of a single viable microorganism on a sterilized device is one in one million. For ECG electrodes, EO sterilization is preferred over gamma irradiation because the conductive gel and pressure-sensitive adhesive are heat- and radiation-sensitive; gamma can cause crosslinking changes that affect both gel conductivity and adhesive peel-force.
7-step verification protocol (30 minutes per supplier)
Short answer: a supplier compliance verification can be completed in 15 to 30 minutes using only public databases and the supplier's certificate documents. The protocol below is the practical sequence used in tender review and accreditation audits.
- Request original certificate PDFs (not screenshots, not first-page only). Specifically: 510(k) clearance letter, full CE certificate including all scope pages, ISO 13485 certificate including scope page, ISO 10993-5/-10/-23 third-party test reports, AAMI EC12 lot-level test report (most recent three lots), MDSAP audit summary if claimed.
-
Verify FDA 510(k) at the FDA database. Search by K-number at
accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. Confirm: applicant matches supplier; Product Code = DRX; clearance date; decision = "SE" (Substantially Equivalent); device description matches the SKU on the quote. -
Verify the CE Notified Body at NANDO. Look up the four-digit number from the CE certificate at
ec.europa.eu/growth/tools-databases/nando/. Confirm: designated under Regulation 2017/745 (not Directive 93/42/EEC); scope includes Class IIa electrocardiograph electrodes; designation status current. -
Verify the ISO 13485 certification body at IAF MLA. Confirm the issuing body is an IAF MLA signatory at
iaf.nu. Use the body's online verifier to confirm the certificate is current. Confirm the scope page explicitly references ECG electrodes. - Cross-check legal entity, manufacturing address, and shipping address. The legal entity on the FDA listing, the certificate, the quotation, and the proforma invoice should all match. Discrepancies indicate trading-company intermediaries that may not be the actual manufacturer.
- Verify the ISO 10993 test article matches the actual product. Read the "test article" / "sample description" section of each ISO 10993-5, -10, and -23 report. The adhesive type, gel formulation, and configuration must match the SKU you are buying. Generic family reports without specific SKU identification are inadequate for Class II skin-contact devices.
- Request lot-level AAMI EC12 reports and verify numerical values. The three most recent production lots should be available in the supplier's quality system. Verify all five EC12 parameters are reported as numerical values (not "compliant"). Wide inter-lot variance within limits indicates marginal manufacturing.
Region-by-region "must have" vs "nice to have"
Short answer: regulatory requirements vary by destination market. The minimum required documentation depends on where the electrodes will be used; "nice to have" certifications smooth customs clearance, accreditation audits, and downstream re-registration in adjacent markets.
| Destination market | Mandatory | Strongly preferred |
|---|---|---|
| United States | FDA authorization under Product Code DRX (510(k) and/or special-controls conformance); Establishment Registration; Device Listing; ISO 13485 | MDSAP; ISO 10993-5/-10/-23; AAMI EC12 lot-level reports |
| European Union | CE marking under MDR 2017/745 with Notified Body number; EC REP; EUDAMED registration; ISO 13485 | MDSAP; ISO 10993-5/-10/-23; UDI assignment evidence |
| United Kingdom | UKCA marking (or recognized CE mark per current MHRA transition rules); UK Responsible Person; ISO 13485 | MDSAP; ISO 10993; FDA 510(k) (often referenced in tenders) |
| Canada | Health Canada Medical Device Licence; MDSAP (mandatory for Class II since 2019); ISO 13485 | FDA 510(k); CE marking |
| Brazil | ANVISA registration (RDC 751/2022); BPF (Brazilian GMP); ISO 13485 + Brazilian-recognized issuer | MDSAP (recognized for ANVISA submissions); INMETRO conformity assessment |
| Australia | TGA inclusion in the ARTG; MDSAP recognized | FDA 510(k); CE marking |
| Japan | PMDA marketing approval / notification (Class II); J-MDR | MDSAP recognized |
| China | NMPA Class II registration certificate; domestic GMP; ISO 13485 (recognized) | MDSAP; FDA 510(k) |
Practical implication for international distributors: sourcing from a manufacturer with simultaneous FDA + CE MDR + MDSAP + NMPA + ISO 13485 + ISO 10993 coverage substantially reduces re-registration friction across markets. MDSAP in particular consolidates audits across FDA, Health Canada, ANVISA, TGA, and PMDA — a single audit with multi-country recognition is an underused procurement leverage point.
Frequently asked questions
Q1: Are ECG electrodes "FDA approved"?
Technically no. The FDA does not "approve" Class II devices — historically it clears them through 510(k), and ECG electrodes also fall under a Class II special-controls framework. "FDA approved" is the term for Class III devices reviewed through PMA. Disposable ECG electrodes are Class II under 21 CFR 870.2360 (Product Code DRX). Suppliers using "FDA approved" loosely are either uninformed or blurring the distinction.
Q2: Do "compatible" replacement ECG electrodes need their own FDA authorization?
Yes. Even when marketed as "compatible with Philips" or "compatible with GE," the manufacturer must hold its own FDA authorization (a 510(k) clearance where one applies, plus conformance to the applicable Class II special controls) and meet the performance and biocompatibility requirements. Compatibility describes the physical/electrical interface; regulatory authorization is a separate fact. Marketing a compatible electrode without it is illegal U.S. marketing of an unauthorized Class II device.
Q3: Is "FDA Registered" the same as "FDA Cleared"?
No. FDA Establishment Registration (Form FDA 2891) is an annual facility listing. FDA Device Listing (Form FDA 2892) identifies which products a facility makes. Neither is a clearance. FDA 510(k) clearance is the review of a specific product's substantial equivalence and is the one that authorizes U.S. marketing for a Class II device that is not exempt.
Q4: What is a K-number and how do I look one up?
A K-number is an identifier following the letter K (e.g., K252345) assigned to each 510(k) submission. The first two digits encode the FDA fiscal year of receipt; the rest are sequential. Look it up at the FDA 510(k) Premarket Notification database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm); the result links to the 510(k) Summary describing the device, predicate, indications, and performance standards.
Q5: Is ISO 9001 enough for an ECG electrode supplier?
No. ISO 9001 is generic. For medical-device manufacturing — including disposable ECG electrodes as Class II skin-contact devices — the standard is ISO 13485, which adds design control, sterilization-process validation, biocompatibility, traceability, adverse-event handling, and CAPA. ISO 9001-only is a disqualifying signal regardless of how impressive other documentation looks.
Q6: Are old MDD CE certificates still valid in the EU in 2026?
For Class IIa devices including disposable ECG electrodes, the MDR transition for many devices concluded in 2024. Old MDD-era certificates (citing Directive 93/42/EEC) generally cannot support new EU market entry in 2026; an electrode must hold a valid MDR certificate citing Regulation (EU) 2017/745 from a Notified Body designated under MDR. Always confirm the certificate cites the Regulation, not the older Directive, and check the current transition rules.
Q7: How long does it take to verify a supplier's compliance?
Using the 7-step protocol with public databases, basic verification takes 15 to 30 minutes: 510(k) lookup at the FDA database (5 min), Notified Body verification at NANDO (5 min), ISO 13485 issuer verification at IAF MLA (5 min), and a document cross-check (10 min). A full audit including AAMI EC12 third-party retest and ISO 10993 review extends to 1–2 weeks.
Q8: What does ISO 10993-10 actually prove?
ISO 10993-10 is the standard for skin-sensitization testing on the actual electrode adhesive and gel materials. A negative result means the test article did not cause an allergic-type immune response in the standardized model. Combined with ISO 10993-23 (skin irritation, 2021) and ISO 10993-5 (cytotoxicity), it forms the regulatory basis for any "hypoallergenic" or "low-allergy" claim — but only when the report is on the actual production formulation.
Q9: Are MDSAP-certified manufacturers automatically FDA cleared?
No. MDSAP is a quality-management-system audit program, not a product clearance. A manufacturer can hold MDSAP certification and still need separate FDA authorization for each product family marketed in the U.S. MDSAP and 510(k) are independent mechanisms; the strength of MDSAP is that it consolidates the QMS audit across FDA, Health Canada, ANVISA, TGA, and PMDA.
Q10: What's the simplest test that disqualifies an ECG electrode supplier?
If a supplier cannot, on request, produce: (a) a verifiable K-number (or documented special-controls compliance) for U.S. sales, (b) a CE certificate citing Regulation 2017/745 with a NANDO-verifiable Notified Body for EU sales, (c) an ISO 13485 scope page explicitly mentioning ECG electrodes from an IAF MLA-recognized issuer, and (d) recent ISO 10993-5/-10/-23 third-party reports on the actual production formulation — the supplier is not qualified for Class II skin-contact procurement, regardless of price or delivery terms.
How MedLinket stands up to the verification protocol
For procurement, distributor, and OEM teams using this protocol — here is how MedLinket's documentation answers each layer of the framework. The same evidence we encourage you to demand from any supplier.
| Layer | MedLinket evidence |
|---|---|
| FDA authorization (Product Code DRX) | FDA 510(k) cleared (13 cleared + 6 Exempt) under Product Code DRX and related codes |
| FDA Establishment Registration + Device Listing | Active registration; full device listing on file |
| CE marking under MDR 2017/745 | CE marked under MDR 2017/745 (14 Class II) with Notified Body designation; 12 Class I |
| UK MHRA | 17 Class II + 22 Class I registrations |
| ISO 13485:2016 | Certified; scope covers ECG electrode manufacturing; ISO 9001:2015 also held |
| MDSAP | Certified; covers FDA / Health Canada / ANVISA / TGA / PMDA |
| NMPA (China) | 33 Class II registrations (+16 Class I) |
| Brazil ANVISA | 32 product registrations (BPF + RDC 751/2022) |
| Australia TGA | 8 ARTG inclusions |
| Japan PMDA | 8 product approvals / notifications |
| ISO 10993-5/-10/-23 | Third-party biocompatibility test reports for the V0014 / V0015 series adhesive and gel formulations |
| AAMI EC12 lot-level performance | Registered platform values: AC impedance 109 Ω · DC offset 4.11 mV · combined offset instability & noise 49.5 µV — all well within EC12 limits (request the lot-level report for a specific SKU) |
| EN ISO 11135 EO sterilization | Validated for sterile-coded (-S-) variants; SAL = 10⁻⁶ |
| Manufacturing facilities | Dual self-owned manufacturing base (Shenzhen HQ + Shaoguan); supports regulatory inspections and customer audits |
All certificates, K-numbers, Notified Body numbers, and lot-level test reports are available to qualified buyers via the channels below.
Request the complete compliance documentation pack
Receive the full verification pack: scanned FDA 510(k) clearance letters with K-numbers · CE certificate including all scope pages · ISO 13485 certificate including scope page · MDSAP audit summary · NMPA / ANVISA / TGA / PMDA / MHRA registration scans · ISO 10993-5/-10/-23 third-party biocompatibility reports · AAMI EC12 lot-level test reports for the three most recent production lots · EN ISO 11135 EO sterilization validation for the sterile (-S-) series.
📧 Email shopify@medlinket.com with your company name, role, destination market, and SKU set of interest.
💬 WhatsApp our regulatory affairs team: +852 6467 3105
📦 Request the compliance pack → Browse disposable ECG electrodesReferences & standards / sources
U.S. federal regulations
- 21 CFR Part 807, Subpart E — Premarket Notification (510(k)) procedures.
- 21 CFR 870.2360 — "Electrode, electrocardiograph" classification; Product Code DRX; Class II special controls.
- FDA Class II Special Controls Guidance: Electrocardiograph Electrodes — the special-controls document defining device-description, biocompatibility, electrical-performance, adhesive-performance, shelf-life, and sterility expectations (effective 2011).
- 21 CFR Part 820 / QMSR — Quality System Regulation; the Quality Management System Regulation (QMSR), effective February 2, 2026, incorporates ISO 13485:2016 by reference.
- FDA 510(k) Premarket Notification database — public lookup at accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm.
- FDA Establishment Registration & Device Listing database — public lookup at accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm.
EU regulations
- Regulation (EU) 2017/745 (MDR) — Class IIa requirements applicable to disposable ECG electrodes.
- EU NANDO database — Notified Body designation lookup at ec.europa.eu/growth/tools-databases/nando/.
- EUDAMED — European Database on Medical Devices.
International quality & performance standards
- ISO 13485:2016 — Medical devices — Quality management systems.
- ANSI/AAMI EC12:2000(R)2020 — Disposable ECG Electrodes.
- ANSI/AAMI EC53 — ECG Cables and Leadwires.
- IEC 60601-1-8 — Alarm systems in medical electrical equipment.
- IEC 60601-2-27 — Electrocardiographic monitoring equipment.
Biocompatibility standards
- ISO 10993-1 — Evaluation and testing within a risk-management process.
- ISO 10993-5 — In-vitro cytotoxicity.
- ISO 10993-10 — Skin sensitization.
- ISO 10993-23 — Skin irritation (introduced 2021).
- ISO 10993-7 — Ethylene oxide sterilization residuals.
- ISO 10993-18 — Chemical characterization of materials.
Sterilization & packaging standards
- EN ISO 11135 — Ethylene oxide sterilization.
- ISO 11607-1 — Sterile barrier system requirements.
- ISO 11607-2 — Sterile barrier system validation.
- ISO 11737-1 — Bioburden determination.
Audit & recognition programs
- MDSAP — Medical Device Single Audit Program (FDA, Health Canada, ANVISA, TGA, PMDA).
- IAF MLA — International Accreditation Forum Multilateral Recognition Arrangement; signatory list at iaf.nu.
Internal product references
- MedLinket internal product-specification documentation — V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) series; SKU codes, AAMI EC12-tested platform values, biocompatibility test articles, sterile-barrier validation. Available on request via shopify@medlinket.com.
- MedLinket internal regulatory-affairs documentation — list of FDA 510(k) K-numbers, CE Notified Body numbers, ISO 13485 certificate, MDSAP audit summary, and regional registrations. Available to qualified buyers under NDA.
- Patent CN202120112524.5 — MedLinket eccentric (offset) ECG electrode structural design, granted utility-model patent, publicly searchable in the CNIPA database. One of multiple patents in the MedLinket portfolio.
Continue reading
Related articles in the MedLinket ECG Electrodes Resource Hub:
- ECG Electrodes: The Complete Buyer's & Clinical Guide (2026) — the parent pillar covering structure, sizing, material, and clinical scenarios.
- How to Evaluate ECG Electrode Suppliers: 12 Must-Check Criteria — the broader supplier scoring framework that contextualizes these regulatory checks.
- OEM-Compatible ECG Electrodes Guide — brand-by-brand cross-reference and substantial-equivalence detail.
- 4.0 mm Snap ECG Electrodes Guide — engineering deep-dive on the connector specification.
- Low-Allergy ECG Electrodes Explained — the ISO 10993-10/-23 evidence base for hypoallergenic claims.
- Offset vs. Center-Post ECG Electrodes — laboratory test data and EC12-margin clinical impact.
- ECG Electrodes by Patient Type — adult, pediatric, neonatal, and sensitive-skin selection.
- Disposable vs. Reusable ECG Electrodes — total-cost-of-ownership context.
- Sterile ECG Electrodes Clinical Guide — the 9-scenario sterile-vs-non-sterile framework.
- How ECG Electrodes Are Made — 6-layer structure, 12-step process, AAMI EC12 measured data.
About MedLinket
MedLinket (Shenzhen Med-link Electronics Tech Co., Ltd) has specialized in capturing and transmitting vital biological signals since 2004, and listed on China's New Third Board (NEEQ) in 2015 — described in company materials as the first listed Chinese company in the monitoring-consumables sector. The company holds 33 NMPA Class II registrations and is FDA 510(k) cleared, CE marked under MDR 2017/745, and certified to ISO 13485:2016, ISO 9001:2015 and MDSAP, with additional registrations across MHRA, ANVISA, TGA and PMDA.
Its intellectual-property portfolio includes multiple patents covering structural design, materials, algorithms, and appearance. The MedLinket V0014 (metal-snap) and V0015 (carbon-snap, radiolucent) ECG electrode series — available in sterile (-S-) and non-sterile variants across the standard size range from the smallest round size (Φ25 mm, used for neonatal/infant monitoring) up to adult Holter (70.5 × 55 mm), including the patented eccentric (offset) thin-neck FPC structural design under utility-model patent CN202120112524.5 — supply 2,000+ hospitals across 110+ countries, with 14 countries recording annual sales above USD 1 million. Product-liability insurance is carried up to USD 5M, with distributors able to request additional-insured status during the policy period.
Inquiry response within 1 hour; repair / quotation turnaround within 2 days; the company supports regulatory inspections and customer audits. Full compliance documentation is available to qualified buyers via shopify@medlinket.com or WhatsApp +852 6467 3105. (Brand names are referenced for compatibility only and imply no OEM or endorsement relationship.)
⚠️ Regulatory & procurement disclaimer. This article is for procurement, regulatory-affairs, and BMET education only. It is not legal advice and is not a substitute for consultation with qualified medical-device regulatory counsel in your destination market. Regulatory environments evolve continuously — verify the current text of all cited regulations (FDA 21 CFR Parts 807 and 820 / QMSR, EU MDR 2017/745, ISO 13485:2016, the ISO 10993 series, AAMI EC12, EN ISO 11135, ISO 11607) directly with the issuing authority before using citations in formal tender, registration, or audit documents.
Standards revisions, transition deadlines, and certificate-renewal timelines change; the information above reflects the landscape as understood at publication. Performance figures attributed to MedLinket are from internal product-specification and laboratory test documentation; equivalence to other suppliers' products requires identical test method and standard reference. Always conduct local validation against your destination-market regulatory authority and follow institutional procurement policies.
Part of MedLinket's ECG Electrodes Resource Hub. Last reviewed by the Regulatory Affairs Director, MedLinket Quality & Regulatory Team — June 2026.
